Benign neoplasm of other and ill-defined parts of digestive system
Description
pancreatic neuroendocrine tumor: Pancreatic endocrine tumor, also known as pancreatic neuroendocrine tumor (PNET), describes a group of endocrine tumors originating in the pancreas that are usually indolent and benign, but may have the potential to be malignant. They can be functional, exhibiting a hormonal hypersecretion syndrome, but can be non-functional presenting with non-specific symptoms and include insulinoma, glucagonoma, VIPoma, somatostatinoma (SSoma), PPoma and Zollinger-Ellison syndrome (ZES, or gastrinoma) and other ectopic hormone producing tumors (such as GRFoma) (see these terms).
Data source
| FinnGen phenocode | CD2_BENIGN_OTHERDIGESTIVE |
| Hospital Discharge registry | ICD-10: D13 |
| Cause of Death registry | ICD-10: D13 |
| Include | CD2_BENIGN_OESOPHAGUS, CD2_BENIGN_STOMACH, CD2_BENIGN_SMALL_INTESTINE, CD2_BENIGN_LIVE_BILE, CD2_BENIGN_PANCREAS, CD2_BENIGN_ENDOCRINE_PANCREAS, CD2_BENIGN_DIGESTIVE_NOS |
| Level in the ICD-hierarchy | 2 |
| First defined in version | DF2 |
Key figures
| Sex | All | Female | Male |
| Number of individuals | 1397 | 893 | 504 |
| Unadjusted prevalence (%) | 1.05 | 1.19 | 0.88 |
| Mean age at first event (years) | 60.67 | 59.37 | 62.97 |
| Median number of events / individual | 1 | 1 | 1 |
Clinical metrics
| Sex | All | Female | Male |
| Recurrence within 6 months (%) | 20.26 | 19.71 | 21.23 |
| Case fatality at 5-years (%) | 7.16 | 5.38 | 10.32 |